Oruka Therapeutics ORKA
NASDAQ ORKA
$93.34 +2.35 (+2.58%)
As of: Sep 4, 2026 · 2:24 PM EDT

Oruka Therapeutics (ORKA) EPS (Diluted) (2010 - 2024)

Analysis

Oruka Therapeutics (ORKA) EPS (Diluted) (2010 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 138.87 Bn 131.01 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 85.57 Bn 77.57 Bn 3.93 Bn 12.23
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn 7.15
4 Moderna 58.19 Bn 53.05 Bn 52.00 Mn -1.96
5 Revolution Medicines 44.07 Bn 44.07 Bn - -3.06
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn 2.05
7 Alnylam Pharmaceuticals 35.38 Bn 32.07 Bn 992.69 Mn 1.19
8 Royalty Pharma 28.42 Bn 27.58 Bn - 0.15
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn -0.06
10 Oruka Therapeutics 5.87 Bn 4.14 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -2.22
Mar 31, 2024 -1.66
Dec 31, 2023 -0.91
Sep 30, 2023 -1.19
Jun 30, 2023 -1.23
Mar 31, 2023 -1.12
Dec 31, 2022 -0.98
Sep 30, 2022 -1.94
Jun 30, 2022 -2.62
Mar 31, 2022 -2.72
Dec 31, 2021 -4.90
Sep 30, 2021 -3.92
Jun 30, 2021 -4.03
Mar 31, 2021 -3,057.42
Dec 31, 2020 -2,302.01
Sep 30, 2020 -1,484.71
Jun 30, 2020 -970.92
Mar 31, 2020 -984.34
Dec 31, 2019 -180.46
Sep 30, 2019 -862.04